Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Reconciliation of GAAP net income per share - diluted to non-GAAP net income per share - diluted:
Shares diluted GAAP
Shares diluted non-GAAP (b)
GAAP net income per share - diluted
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related and other expenses, net of reversals
Amortization of debt issuance costs
Non-GAAP dilutive shares impact from convertible note hedge transaction (b)
Tax effect of the adjustments above (2)
Non-GAAP net income per share - diluted
Reconciliation of GAAP net income to non-GAAP EBITDA):
GAAP net income
Share-based compensation expense
Interest (income) and expense, net
Depreciation and amortization expense
Acquisition accounting impact related to deferred revenues
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related and other expenses, net of reversals (d)
Amortization of debt issuance costs
Provision for income taxes
Non-GAAP EBITDA
Non-GAAP EBITDA margin (non-GAAP EBITDA as a % of total non-GAAP revenues)
(2)
(b)
$
$
$
Three Months Ended September 30,
2023
2022
$
13.6%
45,595
45.595
0.12
0.33
0.16
0.01
(0.00)
0.03
(0.01)
0.02
(0.04)
0.62
5,553
14,982
(5,247)
21,542
246
$
$
$
(184)
1,348
(581)
1,048
1,829
40.536 $
17.4%
45,819
45,384
0.37
0.38
0.19
0.00
0.01
0.01
0.02
0.06
0.02
0.00
(0.06)
1.00
16,774
17,310
(1,136)
21,826
183
251
297
1,027
Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21% for both fiscal years 2023 and 2022.
For the three months ended September 30, 2022, non-GAAP diluted shares excluded approximately 0.4 million shares related to the impact of dilutive convertible senior notes for which the
Company is economically hedged through its anti-dilutive convertible note hedge transaction.
(C)
Defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation, as well as excluding certain other non-GAAP adjustments.
(d) For the three months ended September 30, 2022, other expenses included approximately $0.7 million of certain litigation expenses.
2,494
1,042
543
60,611
24View entire presentation